COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas

How to Cite

OrthoEvidence. COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas. ACE Report. 2022;255(3):35. Available from: https://myorthoevidence.com/AceReport/Report/14726

Study Type:Meta analysis

OE Level Evidence:N/A

Journal Level of Evidence:N/A

Primary sarcomas of the spine: a systematic review and pooled data

Contributing Authors:
P Kooner J Gaffar M Rizkallah R Turcotte A Aoude

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Access conference website and list of abstracts.

Synopsis

Eleven studies including 150 spinal sarcoma patients were included in this meta-analysis assessing the effect of surgical resection types and adjuvant therapies on patient survival. The outcomes of interest included overall mortality/survival and local recurrence. Significantly greater overall survival was observed with en-bloc resection vs. piecemeal resection for spine chondrosarcomas and Ewing ...